Trastuzumab in Metastatic Breast Cancer After Complete Remission: How Long is Enough?

dc.contributor.authorOguz, Arzu
dc.contributor.authorRahatli, Samed
dc.contributor.authorAltundag, Ozden
dc.contributor.authorAltundag, Kadri
dc.contributor.orcID0000-0003-3163-7429en_US
dc.contributor.orcID0000-0003-0197-6622en_US
dc.contributor.orcID0000-0001-6512-6534en_US
dc.contributor.pubmedID26123599en_US
dc.contributor.researcherIDAAJ-3047-2021en_US
dc.contributor.researcherIDW-9219-2019en_US
dc.contributor.researcherIDW-8004-2019en_US
dc.date.accessioned2024-01-26T10:19:04Z
dc.date.available2024-01-26T10:19:04Z
dc.date.issued2015
dc.identifier.eissn1559-131Xen_US
dc.identifier.issn1357-0560en_US
dc.identifier.issue8en_US
dc.identifier.scopus2-s2.0-84933520139en_US
dc.identifier.urihttp://hdl.handle.net/11727/11336
dc.identifier.volume32en_US
dc.identifier.wos000358667700002en_US
dc.language.isoengen_US
dc.relation.isversionof10.1007/s12032-015-0648-1en_US
dc.relation.journalMEDICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleTrastuzumab in Metastatic Breast Cancer After Complete Remission: How Long is Enough?en_US
dc.typeLetteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: